Therapeutic Asset Ratings
1,179 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Abemaciclib
Colon Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
Pegargiminase
Prostate Cancer
M.D. Anderson Cancer Center
P1/2
CC
(46)
Utomilumab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
Utomilumab
Prostate Cancer
M.D. Anderson Cancer Center
P1/2
CC
(46)
Blinatumomab
High Grade B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Blinatumomab
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer Center
P1/2
CC
(45)
Car.70/Il15-Transduced Cb-Nk Cells
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(45)
Cytokine-Treated Veto Cells
Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Evorpacept
Richter Transformation
M.D. Anderson Cancer Center
P1/2
CC
(45)
Fludarabine
Head And Neck Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Fludarabine
Malignant Mesothelioma
M.D. Anderson Cancer Center
P1/2
CC
(45)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Prostate Cancer
M.D. Anderson Cancer Center
P1/2
CC
(45)
Inotuzumab Ozogamicin
High Grade B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Inotuzumab Ozogamicin
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer Center
P1/2
CC
(45)
Ivuxolimab
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Ksq-001Ex
Head And Neck Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
ly3295668
Lung Cancer
M.D. Anderson Cancer Center
P1/2
CC
(45)
MERCAPTOPURINE ANHYDROUS
High Grade B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
MERCAPTOPURINE ANHYDROUS
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer Center
P1/2
CC
(45)
Mesenchymal Stem Cells Derived Exosomes
Pancreatic Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Nezastomig
Prostate Cancer
M.D. Anderson Cancer Center
P1/2
CC
(45)
Pevonedistat
Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Valemetostat
Castration-Resistant Prostate Carcinoma
M.D. Anderson Cancer Center
P1
CC
(44)
Copanlisib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(44)
Utomilumab
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(44)
Showing 801 to 825 of 1,179 assets
Previous
Page 33 of 48
Next
